Prevalence of Healthcare Barriers among US Adults with Chronic Liver Disease Compared to Other Chronic Diseases

Background and Aims The extent of healthcare barriers and its association with acute care use among adults with chronic liver disease (CLD) relative to other chronic conditions remains understudied. We compared the probability of barriers and recurrent acute care use among persons with CLD and persons with chronic obstructive pulmonary disease (COPD) and/or cardiovascular disease (CVD). Methods We assembled a population-based, cross-sectional study using pooled self-reported National Health Interview Survey data (2011-2017) among community-dwelling persons. Probability of barriers by disease group (CLD vs. COPD/CVD) was assessed using hurdle negative binomial regression. Results The sample included 47,037 adults (5,062 with CLD, 41,975 with COPD/CVD). The CLD group was younger (median age 55 vs. 62 years) and included more Hispanics (17.5% vs. 8.6%) and persons with poverty (20.1% vs. 15.3%) than the COPD/CVD group. More respondents with CLD vs. COPD/CVD reported barriers (44.7% vs. 34.4%), including unaffordability (27.5% vs. 18.8%), transportation-related (6.1% vs. 4.1%), and organizational barriers at entry to (17.6% vs. 13.0%) and within healthcare (19.5% vs. 14.2%). While adults with CLD were more likely to experience at least one barrier (adjusted IRR, 1.12 [1.01-1.24], P=0.03), they were not associated with more (1.05 [1.00-2.71], P=0.06). Probability of recurrent acute care use was associated with more healthcare barriers. Conclusion Findings from this nationally representative sample of over 43 million US adults reveal that persons with CLD have increased probability of healthcare barriers, likely related to their higher prevalence of socioeconomic vulnerabilities compared to persons with COPD/CVD. CLD warrants attention as a priority condition in public policies that direct resources towards high-risk populations.